Alpha-1 anti-trypsin for treating liver diseases
AssigneeHadasit Medical Research Services and Development Ltd.
InventorYaron ILAN
Life of this patent
Estimating the term…
Abstract
Methods of treating liver diseases are provided. Accordingly there is provided a method of treating a liver disease selected from the group consisting of fatty liver disease and chronic liver rejection in a subject in need thereof, wherein said liver disease is not associated with genetic alpha-1 anti-trypsin (AAT) deficiency, the method comprising administering to the subject a therapeutically effective amount of AAT.
Claims6
A method of treating a liver disease selected from the group consisting of fatty liver disease and chronic liver rejection in a subject in need thereof, wherein said liver disease is not associated with genetic alpha-1 anti-trypsin (AAT) deficiency, the method comprising administering to the subject a therapeutically effective amount of AAT, thereby treating the liver disease in the subject.
(canceled)
Dependencies are inferred from the claim text.